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One of the most exciting aspects of modern cell biology is
the potential to make connections between disparate areas
of research, and thus open up new lines of enquiry. Two
recent papers have done just this (Kanazawa et al., 2000;
Im et al., 2001, this issue). Building on the biochemical de-
fect in an inherited metabolic disease (Suzuki, 1998), these
papers reveal an unexpected connection between lipid me-
diators, G protein–coupled receptor (GPCR)
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 signaling,
and cytokinesis mechanism.
Globoid cell leukodystrophy (GLD), or Krabbe’s dis-
ease, is a severe, inherited, metabolic disorder in which
normal myelin formation is blocked, and multinucleate
“globoid cells” accumulate in the brain. The primary de-
fect is an absence of the lipid-degrading enzyme galactoce-
ramidase, which cleaves the galactose headgroup from ga-
lactoceramide (Fig. 1). Galactoceramidase-deficient mice
and dogs provide models for human GLD (Suzuki, 1998).
Unlike some other lipidoses, the primary substrate of the
missing enzyme, galactoceramide, does not accumulate.
Instead, a related lipid metabolite, psychosine (Fig. 1), ac-
cumulates in the brain (Svennerholm et al., 1980). Suzuki
(1998) hypothesized that psychosine is normally broken
down by galactoceramidase, and that in its absence psy-
chosine accumulates, causing death of oligodendrocytes.
These are the cells that normally synthesize galactocer-
amide during myelination, so their death would account
for the absence of galactoceramide buildup, and also GLD
pathology. This “psychosine hypothesis” has stood the test
of time, though the mechanism by which psychosine might
mediate toxic effects was unknown. The multinucleate
globoid cells in GLD are thought to derive from microglia
and macrophages (Kanazawa et al., 2000), but the reason
they accumulate was unknown.
To test the hypothesis that accumulated psychosine
might trigger formation of multinucleate globoid cells,
Kanazawa et al. (2000) treated several cell lines with psy-
chosine at concentrations relevant to GLD. They found
that a premonocyte-like cell line, U937, responded by be-
coming multinucleate over a few days. Cytochemistry and
time-lapse imaging of dividing cells showed that psycho-
sine did not induce cell fusion; rather, it blocked cytokine-
sis, uncoupling mitosis from cell division. This discovery is
the first reported inhibition of cytokinesis by a physiologi-
cally occurring small molecule, and a large step forward in
understanding the pathogenesis of GLD. However, it was
not clear how the target of psychosine might be discov-
ered. Psychosine is a lysolipid, with detergent-like proper-
ties, so its target might in principle be some aspect of
membrane biophysics rather than a specific protein.
While hunting for the ligands of an orphan receptor, Im
et al. (2001) appear to have identified one target of psy-
chosine. It is a GPCR called TDAG8, previously named
for its high expression in T cells undergoing apoptosis
(Choi et al., 1996), but otherwise uncharacterized. Discov-
ering the ligands for “orphan” GPCRs and nuclear recep-
tors (receptors identified by sequence for which ligands
and function are unknown) is an important endeavor.
GPCRs are involved in regulating many aspects of physi-
ology, and GPCR agonists and antagonists constitute one
of the largest categories of therapeutic drugs. Orphan
GPCRs may thus be the targets for drugs of the future. To
understand the physiological role of a GPCR, and obtain
the chemical starting point for drug design, it is important
to identify its physiological ligand (Wilson et al., 1998;
Sautel and Milligan, 2000). GPCRs are notable for the di-
versity of their ligands, including proteins, small mole-
cules, and even photons. An important class of GPCR
ligands is lipid mediators, metabolites of common lipids
that play important and diverse roles in signaling between
and within cells. Considerable effort has been devoted to
identifying the presumed GPCR receptors of sphingosine
containing lipid mediators. Recently, a GPCR receptor for
sphingosylphosphorylcholine (Fig. 1), named OGR1, was
identified (Xu et al., 2000). Im et al. (2000, 2001) were also
interested in identifying new sphingosine receptors, and
they expressed in cells the orphan GPCR, TDAG8, that is
41% identical to OGR1, with the expectation that its
ligand might be a lipid related to sphingosylphosphoryl-
choline. This lipid is structurally related to psychosine;
both are lyso-sphingolipids; that is, sphingolipids that lack
the second fatty acid normally attached as an amide to the
amino group of sphingosine (Fig. 1).
Using standard tests for GPCR activation, changes in in-
tracellular [cAMP] and [Ca
 
2
 
1
 
], Im et al. (2001) found that
TDAG8 is activated by psychosine and related lysosphin-
golipids. Primed by the Kanazawa et al. (2000) paper, they
went on to show that expression of TDAG8 in a cell that
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does not normally express it, together with the addition of
psychosine, promotes accumulation of multinucleate cells.
Completing the connection, Im et al. (2001) showed that
the U937 cells shown by Kanazawa et al. (2000) to become
multinucleate in response to psychosine express TDAG8
endogenously, whereas other cell lines that do not respond
do not express this receptor. Im et al. (2001) concluded
that TDAG8 is the receptor for psychosine and a cytoki-
nesis blocker.
Before exploring the implications, it is worth critiquing
this interesting conclusion. The Ki for pyschosine in
decreasing [cAMP] and increasing [Ca
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] in TDAG8-
expressing cells was 
 
z
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m
 
M, significantly higher than the
Ki for some other signaling lipids binding to their GPCR
receptors. For example, sphingosylphosphorylcholine acti-
vates the related GPCR OGR1 with a Ki of 30 nM. The
relatively low apparent affinity of psychosine for TDAG8
is consistent with TDAG8 being the psychosine receptor
in GLD, where the psychosine accumulates to high con-
centrations. But it argues caution in concluding that psy-
chosine is the normal physiological ligand for TDAG8. A
second potential concern is that psychosine might have ad-
ditional effects that are required in addition to activating
TDAG8 for blocking cytokinesis. Lysolipids are cone
shaped, compared with the more cylindrical shape of lipids
with two hydrocarbon chains, and 
 
m
 
M concentrations of
psychosine might alter the biophysics of the plasma mem-
brane in addition to activating TDAG8. Suzuki (1998)
notes that psychosine causes death of many cells types in
culture with a threshold-like dose–response curve, poten-
tially consistent with detergent-like effects.
Assuming that psychosine binding to TDAG8 alone is
sufficient to block cytokinesis, what are the implications?
Several scenarios, not mutually exclusive, can be consid-
ered. This ligand–receptor pair may represent a physiolog-
ical pathway for regulating cytokinesis, as suggested by Im
et al. (2001). Several cell types in mammals become multi-
nucleate as part of their normal developmental program,
including trophoblast cells, megakaryocytes, and osteo-
clasts. In the case of megakaryocytes, observation in cul-
ture has shown that this is due to uncoupling of mito-
sis from cytokinesis (Nagata et al., 1997). Psychosine
and TDAG8 could be involved in activating a physiolog-
ical multinucleation pathway. The tissue expression of
TDAG8 (Im et al., 2001) is consistent with such a hypothe-
sis, though direct experiment will be needed to test it.
The discovery of a receptor for psychosine, and develop-
ment of a cell-based assay for its activation, open the door
to the medicinal chemistry of this class of lipid mediator.
The pharmaceutical industry has an impressive track
record of developing high affinity, reasonably specific ago-
nists and antagonists for GPCRs once this information is
available (Wilson et al., 1998; Sautel and Milligan, 2000).
Im et al. (2001) suggest that psychosine antagonists might
have therapeutic potential for treating GLD and perhaps
other lipidoses. Given the massive accumulation of psy-
chosine in GLD, it seems likely that providing an exoge-
nous source of galactoceramidase might be required in ad-
dition to a psychosine antagonist to treat the disease
effectively.
What are the implications of these papers for cytokine-
sis mechanism? An important issue is the specificity of the
psychosine/TDAG8 effect on cytokinesis. At the level of
the receptor, the cytokinesis block must be specific.
GPCRs are ubiquitous in mammalian physiology, but
multinucleate cells are rare. An endogenous GPCR recep-
tor for a different lysosphingolipid, sphingosylphosphoryl-
choline, is expressed in the RH7777 cells used by Im et al.
(2001) for TDAG8 expression (Im et al., 2000). Stimu-
lation of these cells with sphingosylphosphorylcholine
caused a decrease in [cAMP] comparable to the psycho-
sine/TDAG8 effect, but no induction of multinucleated
cells. This argues that the effect of psychosine/TDAG8 on
cytokinesis is not simply due to its effects on [cAMP] or
[Ca
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]. More likely, the cytokinesis effect is triggered by
some pertussis toxin–resistant heterotrimeric GTPase that
is specifically coupled to TDAG8. Identification of this
GTPase will be important for mechanistic follow up of the
psychosine effect. At the level of cortical response to psy-
chosine/TDAG8, specificity is less clear, and activated
TDAG8 may effect more than one aspect of cortical dy-
namics. To test for an effect of psychosine on other aspects
of cortical dynamics, Kanazawa et al. (2000) measured pha-
gocytosis. The weak phagocytoic activity of undifferenti-
ated U937 cells, now known to express TDAG8, was in-
hibited by psychosine. The much stronger phagocytic
activity of phorbol ester differentiated U937 was not af-
fected by psychosine. However, it is not clear whether the
Figure 1. Structures of lipids. 
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differentiated U937 cells still express TDAG8, so the im-
plications are inconclusive. Cytological observation by
Kanazawa et al. (2000) revealed one major effect of psy-
chosine on the interphase cortex. Large “clots” of F-actin
formed in undifferentiated, interphase U937 cells exposed
to psychosine (Fig. 2). These clots were present in mono-
nucleate cells, so they are not simply a consequence of
failed cytokinesis. At the EM level, the actin clots were as-
sociated with clusters of vacuoles near the plasma mem-
brane. The vacuoles were reminiscent of some endocytic
compartment, and endosomes are known to associate with
actin (for example, Taunton et al., 2000). These observa-
tions argue for effects of psychosine/TDAG8 on inter-
phase cortical dynamics in addition to their effect on cy-
tokinesis. It is even possible that the block to cytokinesis
induced by psychosine/TDAG8 is a secondary effect, due
to the actin clot interfering with cytokinesis. Within cyto-
kinesis, time-lapse observation showed psychosine-treated
cells initiating furrows, but failing to complete cytokinesis
(Kanazawa et al., 2000). Instead the furrow moved to an
off-center position and regressed. Failure to complete cy-
tokinesis is a common phenotype of mutations in proteins
required for cytokinesis, and can probably arise from sev-
eral distinct problems, including defects in contractile ring
assembly or force generation, defects in new membrane
insertion, and defects in midbody assembly (Glotzer,
1997). As psychosine/TDAG8 causes an accumulation of
actin-surrounded vacuoles in interphase U937 cells, the ef-
fect on cytokinesis might be a block to normal membrane
insertion at the furrow. For example, the signaling path-
ways triggered by psychosine/TDAG8 might interfere
with those required for coordinated contraction and mem-
brane insertion during cytokinesis.
More work is required to address the mechanism by
which psychosine/TDAG8 affects cytokinesis, and perhaps
other cortical processes, and to determine if this pathway
plays a role in physiological formation of multinucleate
cells. The role of toxic lipid mediators in other lipidoses is
also an open question (Suzuki, 1998). The connection that
has now been established between psychosine, TDAG8,
and cytokinesis has already opened new lines of investiga-
tion in these previously unlinked areas. Following these
is likely to shed new light on the complex intersection of
lipid-based signaling pathways and cortical dynamics in-
volving the actin cytoskeleton and membranes. This inter-
section is likely to provide a rich vein for both basic cell bi-
ology and pharmaceutical research to mine in the future.
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Figure 2. DNA (red) and actin (green) staining of psychosine-treated U937 cells. These cells are now known to express TDAG8 (Im et
al., 2001). The images show sequential stages of failed cytokinesis in fixed cells. Note the large “clot” of actin present in all the images.
At the EM level this clot contains many small vesicles. Reproduced from Kanazawa et al. (2000) with permission.